ResMed Aktie
203,40
EUR
+3,30
EUR
+1,65
%
221,23
USD
-1,68
USD
-0,75
%
Werbung
ResMed Aktie Analyse
25.09.17 | ResMed Underweight | Barclays Capital | |
07.04.16 | ResMed Underweight | Barclays Capital | |
27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung